Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP502939.RAaG4A3rQJWHkKQaGt6Wmg4eLdFFztivI6oXWmRbAQ83Q130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP502939.RAaG4A3rQJWHkKQaGt6Wmg4eLdFFztivI6oXWmRbAQ83Q130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP502939.RAaG4A3rQJWHkKQaGt6Wmg4eLdFFztivI6oXWmRbAQ83Q130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP502939.RAaG4A3rQJWHkKQaGt6Wmg4eLdFFztivI6oXWmRbAQ83Q130_provenance.
- NP502939.RAaG4A3rQJWHkKQaGt6Wmg4eLdFFztivI6oXWmRbAQ83Q130_assertion description "[Throughout the treatment, SNV promoted the expression of the anti-inflammatory cytokine interleukin-10 as well as neurotrophic factors commonly considered as beneficial in amyotrophic lateral sclerosis management (glial derived neuroptrophic factor, insulin like growth factor, brain derived neurotrophic factor).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP502939.RAaG4A3rQJWHkKQaGt6Wmg4eLdFFztivI6oXWmRbAQ83Q130_provenance.
- NP502939.RAaG4A3rQJWHkKQaGt6Wmg4eLdFFztivI6oXWmRbAQ83Q130_assertion evidence source_evidence_literature NP502939.RAaG4A3rQJWHkKQaGt6Wmg4eLdFFztivI6oXWmRbAQ83Q130_provenance.
- NP502939.RAaG4A3rQJWHkKQaGt6Wmg4eLdFFztivI6oXWmRbAQ83Q130_assertion SIO_000772 25311268 NP502939.RAaG4A3rQJWHkKQaGt6Wmg4eLdFFztivI6oXWmRbAQ83Q130_provenance.
- NP502939.RAaG4A3rQJWHkKQaGt6Wmg4eLdFFztivI6oXWmRbAQ83Q130_assertion wasDerivedFrom befree-20150227 NP502939.RAaG4A3rQJWHkKQaGt6Wmg4eLdFFztivI6oXWmRbAQ83Q130_provenance.
- NP502939.RAaG4A3rQJWHkKQaGt6Wmg4eLdFFztivI6oXWmRbAQ83Q130_assertion wasGeneratedBy ECO_0000203 NP502939.RAaG4A3rQJWHkKQaGt6Wmg4eLdFFztivI6oXWmRbAQ83Q130_provenance.
- befree-20150227 importedOn "2015-02-27" NP502939.RAaG4A3rQJWHkKQaGt6Wmg4eLdFFztivI6oXWmRbAQ83Q130_provenance.